Clinical Trial Update: Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer

View source ↗

Summary

An Exscientia AI-led study evaluating whether ex vivo drug response (EVDR) correlates with clinical outcomes in epithelial ovarian cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Exscientia AI Limited | Conditions: Epithelial Ovarian Cancer | Status: TERMINATED